Plexiglas(R) Rnew Biopolymer Alloys Win R &D Magazine's 2012 Top 100 Award
November 12, 2012 14:38 ET
|
Altuglas International
KING OF PRUSSIA, Pa., Nov. 12, 2012 (GLOBE NEWSWIRE) -- The R &D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics,...
Extraneous Data Collected in Clinical Trials Cost Drug Developers $4 Billion to $6 Billion Annually, According to Tufts Center for the Study of Drug Development
November 06, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Nov 6, 2012) - One out of every five procedures performed during later stage clinical trials collects extraneous data and costs drug developers more than $1 million per...
Contract Support and Technical Service Providers Expected to Play a Growing Role in Drug Development, According to Tufts Center for the Study of Drug Development
October 17, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Oct 17, 2012) - Drug sponsors and their contract service providers are using more sophisticated, integrated, and coordinated relationship structures to deliver greater...
Oncology Drugs Get Faster Approvals Than Non-Oncology Drugs in U.S., but the Opposite Is True in the EU, According to Tufts Center for the Study of Drug Development
September 05, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Sep 5, 2012) - Approval times for new oncology drugs in the United States during the last decade were shorter than approval times for non-oncology products, while the...
A New Japanese Subsidy Program for Projects Promoting Asian Site Location in Japan
August 31, 2012 17:48 ET
|
JETRO USA - Japan External Trade Organization
SAN FRANCISCO, Aug. 31, 2012 (GLOBE NEWSWIRE) -- The Japan External Trade Organization (JETRO) is pleased to announce a new Japanese subsidy program targeting projects that promote a new Regional...
Drug Companies Are Teaming With Academic Medical Centers to Create New Medicines, According to Tufts Center for the Study of Drug Development
August 07, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Aug 7, 2012) - Drug developers are forging new ways to work with academic medical centers to create the next generation of breakthrough medicines, which is changing the...
RTI Offers Free Licensing for Its RTI Connext Messaging Solution
July 18, 2012 09:02 ET
|
Real-Time Innovations (RTI)
SUNNYVALE, CA--(Marketwire - Jul 18, 2012) - Real-Time Innovations (RTI), the world leader in delivering fast, scalable communications software that addresses the challenges of building and...
Avaya Names 2012 Distinguished Engineers
July 13, 2012 13:04 ET
|
Avaya
BASKING RIDGE, NJ--(Marketwire - Jul 13, 2012) -
Avaya names Hamid Assarpour as Avaya's first Senior Distinguished Engineer; appoints six additional Distinguished...
U.S. Cancer Patients Get Faster Access to More Oncology Drugs Than European Patients, According to Tufts Center for the Study of Drug Development
July 10, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jul 10, 2012) - Cancer patients in the United States get faster access to more oncology drugs to treat their disease than patients in Europe, according to a newly...
R&D Employees' Top Challenge Is Lack of Access to Existing Knowledge and Expertise, Coveo Digital Poll Reveals
June 20, 2012 08:40 ET
|
Coveo
QUEBEC--(Marketwire - Jun 20, 2012) -
According to a digital poll conducted by Coveo, the unnecessary replication of pre-existing work is the biggest productivity...